You are here

  • Home
  • Archive
  • Volume 22, Issue Suppl 1
  • CP-105 Effectiveness and safety of protease inhibitors telaprevir and boceprevir in the treatment of hepatitis C virus infections in clinical practice

Article metrics

Article menu
Download PDFPDF
Clinical pharmacy
CP-105 Effectiveness and safety of protease inhibitors telaprevir and boceprevir in the treatment of hepatitis C virus infections in clinical practice

 

Online download statistics by month:

Online download statistics by month: March 2015 to March 2024

AbstractFullPdf
Mar 2015500
Apr 20152800
May 2015300
Jun 20151301
Jul 2015800
Aug 2015900
Sep 2015900
Nov 2015900
Dec 2015100
Jan 2016200
Feb 2016701
Apr 2016402
May 2016400
Jun 2016200
Jul 2016701
Aug 2016200
Sep 2016200
Oct 2016200
Nov 2016300
Dec 2016700
Jan 2017600
Feb 2017802
Mar 2017500
Apr 2017200
May 2017300
Jun 2017700
Jul 2017200
Aug 2017400
Sep 20171000
Oct 20171600
Nov 20171300
Dec 20172000
Jan 20189800
Feb 20186200
Mar 20185800
Apr 20186000
May 20189600
Jun 20183400
Jul 20181000
Aug 20181600
Sep 20181800
Oct 20181601
Nov 20184200
Dec 20187200
Jan 20194400
Feb 20194000
Mar 20192200
Apr 2019002
May 2019600
Jul 2019200
Sep 20191200
Nov 2019400
Dec 2019400
Jan 2020400
Feb 2020200
Mar 2020200
May 2020700
Jun 20202200
Jul 20201000
Aug 2020800
Sep 20201400
Oct 20204600
Nov 20206700
Dec 20201800
Jan 2021600
Feb 2021400
Apr 2021600
Oct 2021201
Nov 20211000
Dec 20211000
Jan 20221200
Feb 20221200
Mar 2022400
Apr 2022400
May 2022600
Jun 20221200
Jul 2022600
Aug 2022400
Sep 2022400
Oct 2022800
Nov 2022600
Dec 20221400
Jan 20231000
Feb 2023200
Mar 2023400
Apr 2023400
May 2023800
Jun 20231000
Jul 2023600
Aug 2023400
Sep 2023800
Nov 2023400
Dec 20231000
Jan 2024200
Feb 2024600
Mar 20241200
Total1359011